Baluran, Merlyn N.

HRN: 24-42-16  Sex: Female

Patient Encounter


Audit Details

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
07/15/2024
FLUCONAZOLE 2MG/ML, 100ML (VIAL)
07/15/2024
07/22/2024
IVT
400mg LD, 100mg
OD
Infected DM Foot, Right
Waiting Final Action 

Indication:  Empiric    Type of Infection:  Bone & JointSkin & Soft Tissue    Compliance to guidelines: Compliant To Guidelines

Initial appropriateness: Yes   

Final appropriateness: Yes   

Overall appropriateness: Yes 

Intervention



Type of Intervention done:

                    

           


Acceptance: